Inflammatory Bowel Disease

Top Story

Infliximab biosimilar safe, effective for Crohn’s disease

December 10, 2018
In the Journals

Pseudopolyps do not predict neoplasia in patients with IBD

December 10, 2018
An analysis of 20 years of data — published in Gastroenterology — found that pseudopolyps are not associated with advanced colorectal neoplasia in patients…
In the Journals

IBD linked to increased risk for myocardial infarction

December 10, 2018
Patients with inflammatory bowel disease are at higher risk for myocardial infarction, according to research published in Inflammatory Bowel Diseases. …

Target PharmaSolutions, Bristol-Myers Squibb partner to advance IBD research

December 8, 2018
Target PharmaSolutions has announced a strategic partnership with Bristol-Myers Squibb to conduct a longitudinal observational study that will evaluate patients with…
More Headlines »

Therapeutic Drug Monitoring in Crohn’s Disease: Personalized Approaches for Treatment Optimization

This activity is supported by an educational grant from UCB, Inc.

Despite the proven therapeutic efficacy of anti-tumor necrosis factor (TNF) agents, treatment failures due to primary…
More »
GI Bookshelf

Question 20: A 58-Year-Old Female Underwent A Screening Colonoscopy That Showed A 2.5-Cm Flat Polyp In The Proximal Ascending Colon. I Tattooed The Area And Biopsied The Polyp, Which Was Initially Reported As Hyperplastic. What Should I Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Resource Centers
Meeting News

VIDEO: IBD research shows ‘very favorable’ outcomes for patients

October 8, 2018
More »